{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:52:10Z","timestamp":1769525530748,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["CNKW2024Y34"],"award-info":[{"award-number":["CNKW2024Y34"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["RCJD2022S06"],"award-info":[{"award-number":["RCJD2022S06"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274010"],"award-info":[{"award-number":["82274010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004106","name":"East China Normal University","doi-asserted-by":"publisher","award":["2022JKXYD09004"],"award-info":[{"award-number":["2022JKXYD09004"]}],"id":[{"id":"10.13039\/501100004106","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117425","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:46:53Z","timestamp":1760730413000},"page":"117425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P4","title":["Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine"],"prefix":"10.1016","volume":"242","author":[{"given":"Tiantian","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenmeizi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-8638","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2025.117425_b0005","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/HYPERTENSIONAHA.125.25342","article-title":"Constructing a preeclampsia organoid model to elucidate the mechanism of aspirin","volume":"82","author":"Huang","year":"2025","journal-title":"Hypertension"},{"issue":"2S","key":"10.1016\/j.bcp.2025.117425_b0010","doi-asserted-by":"crossref","first-page":"S963","DOI":"10.1016\/j.ajog.2020.10.023","article-title":"An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array","volume":"226","author":"Yagel","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2S","key":"10.1016\/j.bcp.2025.117425_b0015","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2025.117425_b0020","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"10.1016\/j.bcp.2025.117425_b0025","article-title":"Hypertensive disorders of pregnancy","volume":"381","author":"Wu","year":"2023","journal-title":"BMJ"},{"issue":"2S","key":"10.1016\/j.bcp.2025.117425_b0030","doi-asserted-by":"crossref","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century","volume":"226","author":"Fishel Bartal","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117425_b0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0b013e31823311c1","article-title":"Maternal Health Study Group of the Canadian Perinatal Surveillance System (Public Health Agency of Canada). Incidence, risk factors, and associated complications of eclampsia","volume":"118","author":"Liu","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117425_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200124060-00004","article-title":"Treating hypertension in women of child-bearing age and during pregnancy","volume":"24","author":"Magee","year":"2001","journal-title":"Drug Saf."},{"issue":"13","key":"10.1016\/j.bcp.2025.117425_b0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2165\/00003088-200443130-00001","article-title":"Pharmacokinetics of tocolytic agents","volume":"43","author":"Tsatsaris","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2025.117425_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1092501","article-title":"Pharmaceutical administration for severe hypertension during pregnancy: Network meta-analysis","volume":"13","author":"Deng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117425_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","volume":"223","author":"Bellos","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117425_b0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin. Perinatol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117425_b0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1471-0528.2007.01630.x","article-title":"Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis","volume":"115","author":"Silberschmidt","year":"2008","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.bcp.2025.117425_b0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/1471-0528.16186","article-title":"Effects of tocolysis with nifedipine or atosiban on child outcome: follow-up of the APOSTELIII trial","volume":"127","author":"van Winden","year":"2020","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.bcp.2025.117425_b0075","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2021.04.228","article-title":"Nifedipine disturbs fetal cardiac function during hypoxemia in a chronic sheep model at near term gestation","volume":"225","author":"Alanne","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117425_b0080","article-title":"Chlorpromazine dose for people with schizophrenia","volume":"4","author":"Dudley","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acschemneuro.8b00258","article-title":"Classics in chemical neuroscience: chlorpromazine","volume":"10","author":"Boyd-Kimball","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117425_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"L\u00f3pez-Mu\u00f1oz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.bcp.2025.117425_b0095","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/1471-0528.15662","article-title":"Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population-based study","volume":"126","author":"Fiaschi","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.bcp.2025.117425_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115457","article-title":"Establishment of LC-MS\/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes","volume":"233","author":"Fu","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9606","key":"10.1016\/j.bcp.2025.117425_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/AOG.0b013e3181ac43f2","article-title":"Tocolytic therapy: a meta-analysis and decision analysis","volume":"114","author":"Jacquemyn","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"1 Pt 1","key":"10.1016\/j.bcp.2025.117425_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9378(11)90679-6","article-title":"A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome","volume":"163","author":"Ferguson","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117425_b0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/bdr2.1457","article-title":"The effects of nifedipine and ivabradine on the functionality of the early rat embryonic heart. are these drugs a risk in early human pregnancy?","volume":"111","author":"Ritchie","year":"2019","journal-title":"Birth Defects Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0125","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/s41598-017-17072-z","article-title":"Beyond the Michaelis-Menten equation: Accurate and efficient estimation of enzyme kinetic parameters","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.bcp.2025.117425_b0130","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1021\/acs.jpclett.7b01210","article-title":"Conformational Nonequilibrium Enzyme Kinetics: Generalized Michaelis-Menten Equation","volume":"8","author":"Piephoff","year":"2017","journal-title":"J. Phys. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2025.117425_b0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.116.08773","article-title":"National Birth Defects Prevention Study. Maternal antihypertensive medication use and congenital heart defects: updated results from the national birth defects prevention study","volume":"69","author":"Fisher","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0140","first-page":"99","article-title":"The Michaelis-Menten equation: computing substrate concentration as a function of time without restrictions on the initial conditions","volume":"7","author":"Cheminant","year":"1991","journal-title":"Comput. Appl. Biosci."},{"issue":"26","key":"10.1016\/j.bcp.2025.117425_b0145","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1007\/s00216-019-02076-7","article-title":"A novel GC-MS methodology to evaluate aromatase activity in human placental microsomes: a comparative study with the standard radiometric assay","volume":"411","author":"Augusto","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117425_b0150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/17425255.3.3.331","article-title":"The fate and effects of xenobiotics in human placenta","volume":"3","author":"Myllynen","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117425_b0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","article-title":"Methadone metabolism by human placenta","volume":"68","author":"Nanovskaya","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117425_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117112","article-title":"Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport","volume":"492","author":"Huang","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117425_b0165","article-title":"Aspirin increases estrogen levels in the placenta to prevent preeclampsia by regulating placental metabolism and transport function","volume":"230","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117425_b0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/psp4.13075","article-title":"Use of physiologically-based pharmacokinetic modeling to understand the effect of omeprazole administration on the pharmacokinetics of oral extended-release nifedipine","volume":"13","author":"Tan","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117425_b0175","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.apsb.2022.08.005","article-title":"The role of CYP1A1\/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia","volume":"13","author":"Lu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117425_b0180","article-title":"Construction of cytochrome P450 3A and P-glycoprotein knockout rats with application in rivaroxaban-verapamil interactions","volume":"230","author":"Huang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117425_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116169","article-title":"Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats","volume":"223","author":"Zhang","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117425_b0190","article-title":"CYP3A mediates drug-drug interactions between atorvastatin and omeprazole: evidence from in vitro and in vivo studies","volume":"242","author":"Liang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117425_b0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2017.07.013","article-title":"Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats","volume":"143","author":"Qin","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117425_b0200","doi-asserted-by":"crossref","first-page":"42922","DOI":"10.1038\/srep42922","article-title":"CRISPR knockout rat cytochrome P450 3A1\/2 model for advancing drug metabolism and pharmacokinetics research","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0143-4004(05)80445-X","article-title":"Xenobiotic and steroid-metabolizing monooxygenases catalysed by cytochrome P450 and glutathione S-transferase conjugations in the human placenta and their relationships to maternal cigarette smoking","volume":"11","author":"Pasanen","year":"1990","journal-title":"Placenta"},{"key":"10.1016\/j.bcp.2025.117425_b0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.placenta.2022.09.013","article-title":"Altered activities of CYP1A1 and CYP19A1 enzymes in women using SSRI medication during pregnancy","volume":"129","author":"Sahlman","year":"2022","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.bcp.2025.117425_b0215","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.acthis.2018.06.002","article-title":"Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta","volume":"120","author":"Cizkova","year":"2018","journal-title":"Acta Histochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117425_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(99)00008-3","article-title":"The expression and regulation of drug metabolism in human placenta","volume":"38","author":"Pasanen","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.bcp.2025.117425_b0225","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/humrep\/17.10.2564","article-title":"Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption","volume":"17","author":"Collier","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bcp.2025.117425_b0230","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.toxlet.2018.07.012","article-title":"Transplacental transfer and metabolism of diuron in human placenta","volume":"295","author":"Mohammed","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117425_b0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.steroids.2011.10.013","article-title":"Tissue physiology and pathology of aromatase","volume":"77","author":"Stocco","year":"2012","journal-title":"Steroids"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:28:04Z","timestamp":1769477284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S0006295225006902"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117425","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117425"}}